Phase 3 Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 18 or older.
- People who have been diagnosed with invasive breast cancer (early to locally advanced stages, known as stages I to III), confirmed through a tissue sample test.
- People whose treatment plan includes chemotherapy before or after surgery that contains one of two specific types of drugs — an anthracycline or a taxane.
- People who are also receiving targeted therapies or hormone therapy as part of their cancer treatment, where clinically appropriate.
- People who are able to understand the study information and agree to take part, and who are able to follow the study procedures.
- People with a general health and activity level rated as reasonably functional (a standard medical scale called ECOG, rated 0 to 2 — confirm with trial site for details).
- People who are able to drink enough fluids to stay adequately hydrated.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with a previous neurological condition that could affect thinking or memory, such as a prior stroke, dementia, a brain injury with lasting effects, or other conditions affecting brain function.
- People with uncorrected vision or hearing problems that would make it difficult to complete the thinking and memory tests used in the study.
- People with a history of psychiatric conditions that are not well controlled and that could interfere with thinking and memory assessments.
- People whose kidneys do not filter waste efficiently enough, based on a specific calculation of kidney function (confirm with trial site for details).
- People with a known liver disease.
- People who are pregnant.
- People with heart failure.
- People who have a build-up of fluid in the abdomen (a condition called ascites).
- People with inflammatory bowel disease.
- People who regularly use anti-inflammatory pain medications such as ibuprofen or naproxen (known as NSAIDs).
- People who are currently breastfeeding.
- People who regularly use medications that suppress the immune system, particularly at doses above a certain level (confirm with trial site for details).
- People who have regularly taken creatine supplements within the past three months.
- People with a known allergy to any ingredient in the supplement or placebo being used in the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: pesquisaclinica@idor.org
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in patient-reported cognitive function
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.